To narrow your search, use one or more of the following search menus below.
September 6, 2017
Clinical And Vaccine Immunology
Dumas, EK;Gross, T;Larabee, J;Pate, L;Cuthbertson, H;Charlton, S;Hallis, B;Engler, RJM;Collins, LC;Spooner, CE;Chen, H;Ballard, J;James, JA;Farris, AD;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
… ELISAs were performed as described previously (58). Briefly, 96-well plates were coated at 4C overnight with 1 g/well of recombinant PA or EF (List Biologicals, Campbell, CA). …
Author did not specify which List Labs Anthrax Edema Factor was utilized. List Labs provides Product #178A(Anthrax Edema Factor (EF), Recombinant from B. anthracis) and Product #173B (Anthrax Edema Factor (EF), Recombinant, Mutant S447N from B. anthracis).
August 17, 2017
POSTER
Shine, N.; Suryadi, K.
Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
Materials and Methods
Anthrax lethal factor (Product #169), and the chicken IgY polyclonal anti-LF antibody (Product # 769A) are products
of List Biological Laboratories, Inc. The C8 Starwell Maxi Nunc-Immuno Module Plates (cat# 441653) used for LF
antibody coating and the dimethyl sulfoxide (DMSO) (cat # TS-20684) were purchased from ThermoScientific. The
96-well, black, flat bottom, non binding plates used for the fluorescent plate assay were from Corning (cat # 3991).
Bovine plasma (cat # 7310806) was purchased from Lampire Biological Laboratories.
Sample Preparation: Stock solutions of the fluorogenic substrate, MAPKKide® Plus, were 1.25 mM in DMSO
based on the peptide content determined by elemental analysis. The substrate was diluted in assay buffer:
20 mM HEPES, pH 8.0 containing 0.1% Tween-20. For the microplate assays, the LF was dissolved in neat bovine
plasma and diluted 1:10 in assay buffer. For the HPLC assays, the LF was added to neat bovine plasma and not
diluted.
LF Activity Assays:
Microplate reader: Assays were performed on a SPECTRAmax GEMINI XS fluorescence microplate reader
(Molecular Devices). The cleavage reaction was initiated by addition of the substrate, MAPKKide® Plus. The
concentration was optimized to minimize background fluorescence while maintaining measureable cleavage. For
all experiments the time-dependent increase in fluorescence was monitored at 37°C hourly for 5 or 6 hours followed
by an additional 18 to 18.5 hr overnight incubation at ambient temperature. The excitation wavelength was set to
368 nm and emission to 452 nm with a cutoff filter at 435 nm.
HPLC: The C8 Starwell Maxi Nunc-Immuno Module Plates were coated with 150 μl of a 10 μg/ml solution of
a chicken affinity purified polyclonal IgY antibody to anthrax lethal factor (List Prod # 769A). Plates were incubated
with the IgY overnight at 2-8°C and washed three times with 0.1M Glycine-HCl, pH 2.5. This wash was included to
liberate residual LF retained after the affinity purification of the antibody and was necessary to minimize the background. After 6 washes with PBS containing 0.05% TWEEN-20 (PBST), the anti-LF coated wells were exposed to
300 μl of a series of LF concentrations in neat plasma. The plates were incubated at 22°C for 2 hours. Plates were
then washed 6 times with PBST and 250 μl of 1.25 μM MAPKKide® Plus was added. The reaction was allowed to
proceed for 2, 3.5, and 5 hours at 37°C and overnight at ambient temperature. At each time point 200 μl of the
reaction mixture was removed from replicate wells and placed in HPLC sample vials.
HPLC was performed using a Zorbax Eclipse Plus C18 reverse phase column, 4.6 x 150 mm (Agilent) and a guard
column containing the same resin in a Varian ProStar HPLC system (Agilent). Solvent A was 0.1% TFA in water and
solvent B was 0.1% TFA in acetonitrile. The 16 minute HPLC method was as follows: 25% B for 0.75 minutes;
25 to 45% B in 4.75 minutes; 45 to 100% B in 0.75 minutes; 100% B for 3.75 minutes; 100 to 25%B in 0.67 minutes
and 5.34 minute equilibration with 25% B. The column effluent was monitored using an Hitachi fluorescence detector
with excitation set to 350 nm and emission at 450 nm to detect the free coumarin fluorophore cleaved from
MAPKKide® Plus. The injection volume was 20 µl. The 7-amido-4-methylcoumarin (AMC) peak retention time
was 4.8 minutes.
• Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
• Product #769B – Anti-Lethal Factor from B. anthracis (Chicken lgY)
• Product #532 – MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor
August 17, 2017
POSTER
Suryadi, K.; Shine, N.
Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
Materials and Methods
Anthrax lethal factor (Product #169), and the chicken IgY polyclonal anti-LF antibody (Product # 769A) are products
of List Biological Laboratories, Inc. The C8 Starwell Maxi Nunc-Immuno Module Plates (cat# 441653) used for LF
antibody coating and the dimethyl sulfoxide (DMSO) (cat # TS-20684) were purchased from ThermoScientific. The
96-well, black, flat bottom, non binding plates used for the fluorescent plate assay were from Corning (cat # 3991).
Bovine plasma (cat # 7310806) and sheep plasma (cat# 7319006) were purchased from Lampire Biological
Laboratories. The milk (2% Lucerne) came from the local market.
Sample Preparation: Stock solutions of the fluorogenic substrate, MAPKKide® Plus, were 1.25 mM in DMSO
based on the peptide content determined by elemental analysis. The substrate was diluted in assay buffer:
20 mM HEPES, pH 8.0 containing 0.1% Tween-20. For the microplate assays, the LF was dissolved in neat bovine
plasma and diluted 1:10 in assay buffer. For the HPLC assays, the LF was added to neat bovine, sheep plasma or
2% milk without dilution.
LF Activity Assays:
Microplate reader: Assays were performed on a SPECTRAmax GEMINI XS fluorescence microplate reader
(Molecular Devices). The cleavage reaction was initiated by addition of the substrate, MAPKKide® Plus. The
concentration was optimized to minimize background fluorescence while maintaining measureable cleavage. For
all experiments the time-dependent increase in fluorescence was monitored at 37°C hourly for 5 or 6 hours followed
by an additional 18 to 18.5 hr overnight incubation at ambient temperature. The excitation wavelength was set to
368 nm and emission to 452 nm with a cutoff filter at 435 nm.
HPLC: The C8 Starwell Maxi Nunc-Immuno Module Plates were coated with 150 μl of a 10 μg/ml solution of
a chicken affinity purified polyclonal IgY antibody to anthrax lethal factor (List Prod # 769A). Plates were incubated
with the IgY overnight at 2-8°C and washed three times with 0.1M Glycine-HCl, pH 2.5. This wash was included to
liberate residual LF retained after the affinity purification of the antibody and was necessary to minimize the background. After 6 washes with PBS containing 0.05% TWEEN-20 (PBST), the anti-LF coated wells were exposed to
300 μl of a series of LF concentrations in neat plasma. The plates were incubated at 22°C for 2 hours. Plates were
then washed 6 times with PBST and 250 μl of 1.25 μM MAPKKide® Plus was added. The reaction was allowed to
proceed for 2, 3.5, and 5 hours at 37°C and overnight at ambient temperature. At each time point 200 μl of the
reaction mixture was removed from replicate wells and placed in HPLC sample vials.
HPLC was performed using a Zorbax Eclipse Plus C18 reverse phase column, 4.6 x 150 mm (Agilent) and a guard
column containing the same resin in a Varian ProStar HPLC system (Agilent). Solvent A was 0.1% TFA in water and
solvent B was 0.1% TFA in acetonitrile. The 16 minute HPLC method was as follows: 25% B for 0.75 minutes;
25 to 45% B in 4.75 minutes; 45 to 100% B in 0.75 minutes; 100% B for 3.75 minutes; 100 to 25%B in 0.67 minutes
and 5.34 minute equilibration with 25% B. The column effluent was monitored using an Hitachi fluorescence detector
with excitation set to 350 nm and emission at 450 nm to detect the free fluorophore cleaved from MAPKKide® Plus.
The injection volume was 20 µl. The 7-amido-4-methylcoumarin (AMC) peak retention time was 4.8 minutes.
• Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence
• Product #769B – Anti-Lethal Factor from B. anthracis (Chicken lgY)
• Product #532 – MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor
July 17, 2017
Novel Oral Delivery System; On Drug Delivery
Mohanraj, SM;Kende, M;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
…The MDS formulations were prepared with the following parameters: Matrix materials: poly (dl-lactide-co- glycolide) and poly (dl-lactide) Microsphere mean diameter range: 6-20 m RPA of anthrax (from List Biological Laboratories, Campbell, CA, US …
July 12, 2017
Bmc Veterinary Research
Koehler, SM;Buyuk, F;Celebi, O;Demiraslan, H;Doganay, M;Sahin, M;Moehring, J;Ndumnego, OC;Otlu, S;van Heerden, H;Beyer, W;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
Serology:
…Toxin-neutralizing assay (TNA) was performed as published earlier [53] to qualitatively assess the ability of antibodies generated to neutralize lethal toxin. Briefly, heat inactivated individual sera were serially diluted in 8 log2 steps with a starting dilution of 1:50 on sterile 96 well plates (BD Biosciences, Heidelberg, Germany) seeded with 105 J774 A.1 macrophages per well. Lethal toxin (LF) was added at concentration of 500 ng/mL PA and 100 ng/mL LF (List Biological Laboratories, Campbell, CA, USA) and survival of macrophages was visualized through MTT (5 mg/mL, Alfa Aesar, Karsruhe, Germany), which is degraded by living cells to a measurable (OD540nm) colour compound. …
Author did not indicate which specific lethal factor was utilized. List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).
June 29, 2017
Plos One
Weir, GM;Karkada, M;Hoskin, D;Stanford, MM;MacDonald, L;Mansour, M;Liwski, RS;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
Vaccines and immunization:
…Anthrax vaccine was prepared with recombinant protective antigen (rPA; List Biologicals, Campbell, CA) to deliver 1 g antigen, 1 g poly I:C, and/ or 1 g Pam3CSK4 per 50 L dose.
June 15, 2017
Npj Vaccines
Sim, BK;Li, M;Osorio, M;Wu, Y;Wai, TT;Peterson, JW;James, ER;Chakravarty, S;Gao, L;Xu, R;KC, N;Stafford, RE;Lawrence, WS;Yeager, LA;Peel, JE;Sivasubramani, SK;Chopra, AK;Hoffman, SF;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
Antibody assessment:
Recombinant proteins (rPA and rLF) were …or purchased from List Biological Laboratories (Campbell, CA). Antibody titers against PA were determined by enzyme-linked immunosorbent assay (ELISA). Plates were coated with rPA at 2.0ng/L in a volume of 50L/well and incubated overnight at 4C. Plates were then washed three times with 1wash solution (KPL, Gaithersburg, MD), and blocked with 1% bovine serum albumin (KPL) containing 1% non-fat dry milk for 1h at 37C. …
The lethal toxin-neutralizing assay (TNA) titer was determined as described34 except J774A.1 murine macrophage cells were used. Briefly, the serially diluted sera were pre-incubated with toxin mixture (PA and LF at 5:4 ratio) at 37C for 30min before adding to J774A.1 cells in 96-well plates. …
Author did not indicate which specific lethal factor was utilized. List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).
June 8, 2017
Vaccine
Dumas, EK;Garman, L;Cuthbertson, H;Charlton, S;Hallis, B;Engler, RJM;Choudhari, S;Picking, WD;James, JA;Farris, AD;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
…ELISAs were performed as described [23]. Briefly, 96-well plates were coated with 1 g/well of recombinant PA, LF (List Biologicals, Campbell, CA),…
Author did not indicate which specific lethal factor was utilized. List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence)
June 5, 2017
Nature Communications
Ratsimandresy, RA;Chu, LH;Khare, S;de Almeida, L;Gangopadhyay, A;Indramohan, M;Misharin, AV;Greaves, DR;Perlman, H;Dorfleutner, A;Stehlik, C;
Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis
Macrophage culture:
…BMDMs were primed for 4h with 600ngml1 E. coli 0111:B4 LPS… and then transfected with poly(dA:dT)…, lethal toxin (500ngml1, #172D and #171D mixed at a 50/50 ratio, List Labs) or flagellin…
May 31, 2017
Plos One
Schultz, HS;Reedtz-Runge, SL;Bckstrm, BT;Lamberth, K;Pedersen, CR;Kvarnhammar, AM;, ;
Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis
Proteins:
…Protective antigen (PA) from Bacillus anthracis (List Biological Labs, Campbell, CA, USA) was used in the assay at a final concentration of 3 g/ml. …